Company Ticker News August 10, 2021AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration 0 0 Share
Company Ticker News August 10, 2021AbbVie: Strong Earnings Make Bull Case For Reassuringly Undervalued Pharma 0 0 Share
Press Release August 9, 2021SKYRIZI® (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis 0 0 Share
Company Ticker News August 9, 2021AbbVie: An Undervalued 4.52% Dividend Machine With A Huge Pipeline Of Possibilities 0 0 Share
Press Release August 9, 2021Mission and AbbVie Collaboration in Alzheimer's and Parkinson's Diseases Reaches Next Milestone 0 0 Share
Company Ticker News August 9, 2021AbbVie: Diversified Strength Tempers The Humira Patent Cliff Ahead 0 0 Share
